Inventor
BERNARDS RENE
NL16 patents
⚠️ This page may combine multiple inventors who share the name “BERNARDS RENE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PROLIFIX LTD
7 patentsUS6350572B1Feb 26, 2002
Interaction between cyclin D1 and steroid receptor coactivators and users thereof in assays
PROLIFIX LTD6 citations67
US6368809B1Apr 9, 2002
E2F ubiquitination domain, and assays for inhibitors and enhancers of E2F ubiquitination
PROLIFIX LTD4 citations61
US6303335B1Oct 16, 2001
Transcription factor E2F-4
PROLIFIX LTD4 citations57
US6045999AApr 4, 2000
Transcription factor E2F-4
PROLIFIX LTD2 citations57
US5985283ANov 16, 1999
Adenovirus E1A-Associated protein BS69, inhibitor of E1A-transactivation
PROLIFIX LTD0 citations50
US6448376B1Sep 10, 2002
Transcription factor-E2F-5
PROLIFIX LTD0 citations44
US6033843AMar 7, 2000
Interaction of cyclin D1 and estrogen receptor and its use in assays
PROLIFIX LTD0 citations38
NETHERLANDS CANCER INST
2 patentsSTICHTING HET NEDERLANDS KANKER INST ANTONI VAN LEEUWENHOEK ZIEKENHUIS
2 patentsUS10398696B2Sep 3, 2019
Combinations for treatment of cancer
STICHTING HET NEDERLANDS KANKER INST ANTONI VAN LEEUWENHOEK ZIEKENHUIS0 citations50
US10864179B2Dec 15, 2020
Histone deacetylase inhibitors for the use in the treatment of drug resistant melanoma
STICHTING HET NEDERLANDS KANKER INST ANTONI VAN LEEUWENHOEK ZIEKENHUIS0 citations43